Should patients be allowed to opt out of routine genetic testing of colorectal tumors? Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, October 12, 2016

Should patients be allowed to opt out of routine genetic testing of colorectal tumors?



press release

TORONTO, Oct. 6, 2016--Health-care providers support routine testing of colorectal tumours to identify more individuals who have the most common genetic condition responsible for such cancers, a new study suggests.
And few felt patients should have the right to opt out of this test that would determine whether they have Lynch Syndrome, according to the study by Dr. Yvonne Bombard, a genomics and health services researcher in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.
The study was published online today in the journal Genetics in Medicine.....

 Dr. Bombard interviewed surgeons, genetic counselors, oncologists, primary care physicians and gastroenterologists for their views and experiences on tumor testing, notification of results, counseling patients with Lynch Syndrome and their families, and their vision for the design and implementation of routine testing.
abstract: Universal tumor screening for Lynch syndrome: health-care providers’ perspectives

0 comments :

Post a Comment

Your comments?